SBL
Sargent Bickham Lagudis’s Biogen BIIB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | $3.05K | Sell |
11
-20
| -65% | -$5.54K | ﹤0.01% | 860 |
|
2022
Q3 | $8K | Hold |
31
| – | – | ﹤0.01% | 716 |
|
2022
Q2 | $6K | Hold |
31
| – | – | ﹤0.01% | 758 |
|
2022
Q1 | $6K | Hold |
31
| – | – | ﹤0.01% | 767 |
|
2021
Q4 | $7K | Hold |
31
| – | – | ﹤0.01% | 752 |
|
2021
Q3 | $9K | Hold |
31
| – | – | ﹤0.01% | 729 |
|
2021
Q2 | $11K | Sell |
31
-5
| -14% | -$1.77K | ﹤0.01% | 696 |
|
2021
Q1 | $10K | Buy |
36
+5
| +16% | +$1.39K | ﹤0.01% | 687 |
|
2020
Q4 | $8K | Buy |
31
+20
| +182% | +$5.16K | ﹤0.01% | 685 |
|
2020
Q3 | $3K | Hold |
11
| – | – | ﹤0.01% | 693 |
|
2020
Q2 | $3K | Hold |
11
| – | – | ﹤0.01% | 675 |
|
2020
Q1 | $3K | Hold |
11
| – | – | ﹤0.01% | 669 |
|
2019
Q4 | $3K | Hold |
11
| – | – | ﹤0.01% | 731 |
|
2019
Q3 | $3K | Hold |
11
| – | – | ﹤0.01% | 654 |
|
2019
Q2 | $3K | Hold |
11
| – | – | ﹤0.01% | 689 |
|
2019
Q1 | $3K | Hold |
11
| – | – | ﹤0.01% | 723 |
|
2018
Q4 | $3K | Sell |
11
-16
| -59% | -$4.36K | ﹤0.01% | 695 |
|
2018
Q3 | $10K | Buy |
27
+16
| +145% | +$5.93K | ﹤0.01% | 604 |
|
2018
Q2 | $3K | Sell |
11
-10
| -48% | -$2.73K | ﹤0.01% | 697 |
|
2018
Q1 | $6K | Hold |
21
| – | – | ﹤0.01% | 643 |
|
2017
Q4 | $7K | Hold |
21
| – | – | ﹤0.01% | 645 |
|
2017
Q3 | $7K | Hold |
21
| – | – | ﹤0.01% | 658 |
|
2017
Q2 | $6K | Buy |
21
+10
| +91% | +$2.86K | ﹤0.01% | 632 |
|
2017
Q1 | $3K | Hold |
11
| – | – | ﹤0.01% | 679 |
|
2016
Q4 | $3K | Buy |
+11
| New | +$3K | ﹤0.01% | 650 |
|
2016
Q3 | – | Sell |
-9,576
| Closed | -$2.32M | – | 728 |
|
2016
Q2 | $2.32M | Sell |
9,576
-1,106
| -10% | -$267K | 0.36% | 80 |
|
2016
Q1 | $2.78M | Buy |
+10,682
| New | +$2.78M | 0.45% | 65 |
|